Tower Research Capital LLC (Trc) Collegium Pharmaceutical, Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,711 shares of COLL stock, worth $332,826. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,711
Previous 4,711
148.59%
Holding current value
$332,826
Previous $182,000
84.07%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding COLL
# of Institutions
246Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$165 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$75 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$66.8 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$64.9 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$60.9 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $970M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...